SRT3 logo

Sartorius Aktiengesellschaft Stock Price

XTRA:SRT3 Community·€15.3b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 13 Fair Values set on narratives written by author

SRT3 Share Price Performance

€248.40
29.30 (13.37%)
€191.20
Fair Value
€248.40
29.30 (13.37%)
41.9% overvalued intrinsic discount
€175.00
Fair Value
Price €248.40
AnalystLowTarget €175.00
AnalystHighTarget €310.00
AnalystConsensusTarget €257.25

SRT3 Community Narratives

AnalystLowTarget·
Fair Value €191.2 29.9% overvalued intrinsic discount

Rising Tariffs, Regulatory Hurdles And Cost Pressures Will Squeeze Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystHighTarget·
Fair Value €310 19.9% undervalued intrinsic discount

Cell And Gene Therapies Will Expand Secular Bioproduction

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value €260.05 4.5% undervalued intrinsic discount

Advanced Biologic Adoption Will Expand Global Reach

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
€260.05
4.5% undervalued intrinsic discount
Revenue growth
9.16% p.a.
Profit Margin
8.78%
Future PE
53.51x
Price in 2028
€309.66

Trending Discussion

Updated Narratives

SRT3 logo

Rising Tariffs, Regulatory Hurdles And Cost Pressures Will Squeeze Margins

Fair Value: €191.2 29.9% overvalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
SRT3 logo

Cell And Gene Therapies Will Expand Secular Bioproduction

Fair Value: €310 19.9% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
SRT3 logo

Advanced Biologic Adoption Will Expand Global Reach

Fair Value: €260.05 4.5% undervalued intrinsic discount
7 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Reasonable growth potential with proven track record.

1 Risk
3 Rewards

Sartorius Aktiengesellschaft Key Details

€3.5b

Revenue

€1.9b

Cost of Revenue

€1.6b

Gross Profit

€1.5b

Other Expenses

€133.6m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
1.94
46.48%
3.80%
106.6%
View Full Analysis

About SRT3

Founded
1870
Employees
13878
CEO
Michael Grosse
WebsiteView website
www.sartorius.com

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cytometry; ultrafiltration solutions; syringe, membrane, glass and quartz microfiber, clarification, syringeless, and in-line filters; and lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, and support and services; live-cell imaging and analysis software; contract manufacturing and integration; OEM membranes and devices, weigh cells, and data analytics; connectivity, and pipetting and dispensing products; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and surface plasmon resonance and process filtration products. The company offers water purification systems; lab data and fleet management software; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, weights and weight sets, paint mixing solutions, and weighing accessories; and bioprocess consulting and engineering, biologics testing, cell culture media, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Recent SRT3 News & Updates

Recent updates

No updates